Dasatinib
- Product NDC
- 70748-209
- 11-digit product format
- 707480209
- Labeler code
- 70748
- Product ID
- 70748-209_79f45560-3318-42e3-8be6-fac133dca745
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dasatinib
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA214350
- Marketing category
- ANDA
- Marketing start
- 2026-01-30
- Substance
- DASATINIB
- Active strength
- 50 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| RBZ1571X5H | DASATINIB | 863127-77-9 | DASATINIB |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 70748-209-07 | 70748020907 | 1 BOTTLE in 1 CARTON (70748-209-07) / 60 TABLET in 1 BOTTLE | 1 bottle | 2026-01-30 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Dasatinib | Lupin Pharmaceuticals, Inc. | 2026-02-27 | HUMAN PRESCRIPTION DRUG LABEL | 7 |